Open | $0.765 |
Close | $0.851 |
Volume / Avg. | 2.089M / 2.264M |
Day Range | 0.760 - 0.866 |
52 Wk Range | 0.291 - 2.235 |
Market Cap | $153.842M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | % |
Days to Cover | 9.7 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Sangamo Therapeutics (NASDAQ: SGMO) through any online brokerage.
Other companies in Sangamo Therapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Zura Bio (NASDAQ:ZURA), Molecular Partners (NASDAQ:MOLN), CytomX Therapeutics (NASDAQ:CTMX) and Galectin Therapeutics (NASDAQ:GALT).
The latest price target for Sangamo Therapeutics (NASDAQ: SGMO) was reported by RBC Capital on Thursday, March 14, 2024. The analyst firm set a price target for 2.00 expecting SGMO to rise to within 12 months (a possible 132.59% upside). 18 analyst firms have reported ratings in the last year.
The stock price for Sangamo Therapeutics (NASDAQ: SGMO) is $0.8599 last updated March 18, 2024 at 7:55 PM EDT.
There are no upcoming dividends for Sangamo Therapeutics.
Sangamo Therapeutics’s Q1 earnings are confirmed for Wednesday, April 24, 2024.
There is no upcoming split for Sangamo Therapeutics.
Sangamo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.